ConductScience.org, home

Paper35539722

Synthesis and characterization of amino glucose-functionalized silica-coated NiFe2O4 nanoparticles: a heterogeneous, new and magnetically separable catalyst for the solvent-free synthesis of pyrano[3,2-c]chromen-5(4H)-ones.

Fekri LZ and 3 others. RSC Adv, 2018. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Synthesis and characterization of amino glucose-functionalized silica-coated NiFe2O4 nanoparticles: a heterogeneous, new and magnetically separable catalyst for the solvent-free synthesis of pyrano[3,2-c]chromen-5(4H)-ones. Papers, record 35539722. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35539722

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synthesis and characterization of amino glucose-functionalized silica-coated NiFe2O4 nanoparticles: a heterogeneous, new and magnetically separable catalyst for the solvent-free synthesis of pyrano[3,2-c]chromen-5(4H)-ones.
PubMed
Journal
RSC Adv
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.98
iCite
Revised in PubMed
2024-08-27
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fekri LZLeila Zare
2Nikpassand MMohammadhttps://orcid.org/0000-0002-9692-6849
3Pourmirzajani SSakineh
4Aghazadeh BBehnaz

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124676061Recent advances in the synthesis of pyrroles by multicomponent reactions.Chem Soc Rev2014https://conductscience.org/library/papers/24676061PubMed
221741732Synthesis and identification of β-aryloxyquinolines and their pyrano[3,2-c]chromene derivatives as a new class of antimicrobial and antituberculosis agents.Eur J Med Chem2011https://conductscience.org/library/papers/21741732PubMed
35788176Researches in the field of antiviral compounds. Mannich Bases of 3-hydroxycoumarin.J Med Chem1969https://conductscience.org/library/papers/5788176PubMed
423079527Synthesis and cytotoxicity evaluation of highly functionalized pyranochromenes and pyranopyrans.Bioorg Med Chem Lett2012https://conductscience.org/library/papers/23079527PubMed
526384917An efficient and green synthesis of novel benzoxazole under ultrasound irradiation.Ultrason Sonochem2016https://conductscience.org/library/papers/26384917PubMed
624589860Toward the ideal synthesis and molecular function through synthesis-informed design.Nat Prod Rep2014https://conductscience.org/library/papers/24589860PubMed
712877932Reversal of multidrug resistance in cancer cells by pyranocoumarins isolated from Radix Peucedani.Eur J Pharmacol2003https://conductscience.org/library/papers/12877932PubMed
81379639The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.J Med Chem1992https://conductscience.org/library/papers/1379639PubMed
922435608Chemistry and biology of multicomponent reactions.Chem Rev2012https://conductscience.org/library/papers/22435608PubMed
108035430Phospholipase C inhibitors: a new class of cytotoxic agents.J Med Chem1994https://conductscience.org/library/papers/8035430PubMed
117506311The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn.J Med Chem1993https://conductscience.org/library/papers/7506311PubMed
1221950409Gold(III)-catalyzed tandem conjugate addition/annulation of 4-hydroxycoumarins with α,β-unsaturated ketones.J Org Chem2011https://conductscience.org/library/papers/21950409PubMed

Download CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
35540678Rapid and catalyst free synthesis of new bis(benzo[g]chromene) and bis(pyrano[3,2-c]chromene) derivatives and optimization of reaction conditions using response surface methodology.RSC Adv2019https://conductscience.org/library/papers/35540678PubMed
35516511A decennary update on applications of metal nanoparticles (MNPs) in the synthesis of nitrogen- and oxygen-containing heterocyclic scaffolds.RSC Adv2020https://conductscience.org/library/papers/35516511PubMed
35492548Urazolium diacetate as a new, efficient and reusable Brønsted acid ionic liquid for the synthesis of novel derivatives of thiazolidine-4-ones.RSC Adv2019https://conductscience.org/library/papers/35492548PubMed
34540801Green Synthesis of New Category of Pyrano[3,2-c]Chromene-Diones Catalyzed by Nanocomposite as Fe3O4@SiO2-Propyl Covalented Dapsone-Copper Complex.Front Chem2021https://conductscience.org/library/papers/34540801PubMed
30697671The molecular diversity scope of 4-hydroxycoumarin in the synthesis of heterocyclic compounds via multicomponent reactions.Mol Divers2019https://conductscience.org/library/papers/30697671PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35539722

GET https://conductscience.org/api/papers/v1/35539722/authors